John Samples, MD, shares highlights from his the glaucoma panel discussion during the 2023 Controversies in Modern Eye Care meeting.
John Samples, MD, shares short reflections from the glaucoma panel, "Pearls in comanaging glaucoma," which he co-presented during the 17th annual Controversies in Modern Eye Care symposium at the Skirball Cultural Center in Los Angeles, California.
This transcript has been edited for clarity.
John Samples, MD:
I'm John Samples and I'm in practice in Portland, Oregon, where I'm also a clinical professor at Washington State University College of Medicine. I, for many years, was at the KCI Institute in Portland, Oregon.
I was here today to talk about MIGS and the many different new MIGS that are available and there are really quite a few. This is promising time for glaucoma surgery, and by my count—at ARVO the last week, there were about 50 different types of MIGS that are presently either on the market or under development or in early phases of development.
It's a promising time for that matter. It's also a promising time for ophthalmic medications, and there are many new candidate classes which are extremely interesting and unlike any classes that we've used before.